Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Xilio Therapeutics appointed Yariv J. Houvras, M.D., Ph.D. as chief medical officer, bringing 20+ years in clinical development and immuno-oncology.Material DetailsContext by AI AnalystThis is a management upgrade amid ongoing clinical development of masked immuno-oncology assets, including XTX501…
Dr. Houvras brings over two decades of executive leadership across premier industry and academic research institutions in clinical development, translational medicine and immuno-oncologyWALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. NASDAQ:XLO, a clinical-stage biotechn…
Xilio Therapeutics Appoints Yariv J. Houvras as Chief Medical Officer
Xilio Therapeutics said it appointed Yariv J. Houvras, M.D., Ph.D. as chief medical officer.